Author:
Tod Michel,Goutelle S.,Bleyzac N.,Bourguignon L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference150 articles.
1. Neuvonen PJ. Towards safer and more predictable drug treatment–reflections from studies of the first BCPT Prize awardee. Basic Clin Pharmacol Toxicol. 2012;110(3):207–18.
2. Food and Drug Administration. Guidance for industry: drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations. Rockville: FDA; 2012.
3. European Medicines Agency. Guideline on the investigation of drug interactions. London: Committee for Medical Products for Human Use (CHMP); 2012.
4. Rostami-Hodjegan A, Tucker G. ‘In silico’ simulations to assess the ‘in vivo’ consequences of ‘in vitro’ metabolic drug–drug interactions. Drug Discov Today Technol. 2004;1(4):441–8.
5. Chu X, Korzekwa K, Elsby R, Fenner K, Galetin A, Lai Y, et al. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver. Clin Pharmacol Ther. 2013;94(1):126–41.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献